Chardan Capital Markets initiated coverage on Oculis Holding AG with a new price target

12/5/23 8:03:01 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Chardan Capital Markets initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $30.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OCS

Date	Price Target	Rating	Analyst
12/5/2023	$30.00	Buy	Chardan Capital Markets
10/5/2023	$35.00	Buy	Stifel
6/14/2023	$22.00	Buy	BofA Securities
6/12/2023	$28.00	Buy	H.C. Wainwright
6/8/2023	$58.00	Outperform	Robert W. Baird
5/10/2023	$23.00	Buy	Pareto
4/28/2023	$27.00	Outperform	Wedbush